Search - tctmd.com

Displaying 221 - 240 of 1310

Sort: Relevancy | Date

News Daily News

Tirzepatide Eases Obstructive Sleep Apnea in Patients With Obesity

Todd Neale

April 17, 2024

News Conference News ACC 2024

Vaping Linked to Higher Risk of HFpEF, NIH Data Show

L.A. McKeown

April 12, 2024

News Conference News ACC 2024

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

L.A. McKeown

April 06, 2024

Presentation ACC 2024

Main Results From The Step-hfpef Dm Trial

Presenter: Mikhail Kosiborod

April 06, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2024

Shelley Wood

April 03, 2024

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Conference News ACC 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Michael O'Riordan

March 27, 2024

News Daily News

Physicians (Mostly) Negative on Private Equity in Healthcare

Michael O'Riordan

March 13, 2024

News Conference News THT 2024

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

Michael O'Riordan

March 11, 2024

News Daily News

Patients With CKD Remain Underrepresented in Trials of CV Meds

Todd Neale

March 08, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

Presentation THT Abstracts 2024

Beyond Supine Pulmonary Artery Pressures

Presenter: Marat Fudim

March 05, 2024

Presentation THT 2024

AI in Diagnostics and Therapeutics: Horizons Ahead

Presenter: Harlan Krumholz

March 05, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2024

Shelley Wood

March 01, 2024

News Opinion CV Team Dispatch

March 2024 Dispatch for the CV Team

L.A. McKeown

March 01, 2024

News Daily News

Living Near Bars, Restaurants Linked to Greater Likelihood of HF

L.A. McKeown

February 29, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

BMI Mostly Doesn’t Impact DOACs, Except Maybe at the Extremes

Todd Neale

February 02, 2024

News Opinion CV Team Dispatch

February 2024 Dispatch for the CV Team

L.A. McKeown

February 01, 2024

News Daily News

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Michael O'Riordan

February 01, 2024

Advertisement

Tirzepatide Eases Obstructive Sleep Apnea in Patients With Obesity

Vaping Linked to Higher Risk of HFpEF, NIH Data Show

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

Main Results From The Step-hfpef Dm Trial

TCTMD’s Top 10 Most Popular Stories for March 2024

April 2024 Dispatch for the CV Team

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Physicians (Mostly) Negative on Private Equity in Healthcare

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

Patients With CKD Remain Underrepresented in Trials of CV Meds

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Beyond Supine Pulmonary Artery Pressures

AI in Diagnostics and Therapeutics: Horizons Ahead

TCTMD’s Top 10 Most Popular Stories for February 2024

March 2024 Dispatch for the CV Team

Living Near Bars, Restaurants Linked to Greater Likelihood of HF

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

BMI Mostly Doesn’t Impact DOACs, Except Maybe at the Extremes

February 2024 Dispatch for the CV Team

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content